KR20240032920A - 치료 옵션 및 결과 추적을 제공하기 위한 진행 이정표에 대응하는 정확한 환자 데이터를 제공하기 위한 시스템 및 방법 - Google Patents
치료 옵션 및 결과 추적을 제공하기 위한 진행 이정표에 대응하는 정확한 환자 데이터를 제공하기 위한 시스템 및 방법 Download PDFInfo
- Publication number
- KR20240032920A KR20240032920A KR1020247004016A KR20247004016A KR20240032920A KR 20240032920 A KR20240032920 A KR 20240032920A KR 1020247004016 A KR1020247004016 A KR 1020247004016A KR 20247004016 A KR20247004016 A KR 20247004016A KR 20240032920 A KR20240032920 A KR 20240032920A
- Authority
- KR
- South Korea
- Prior art keywords
- fact
- patient
- candidate
- facts
- data
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 152
- 238000011282 treatment Methods 0.000 title claims description 81
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 129
- 201000010099 disease Diseases 0.000 claims abstract description 111
- 238000003745 diagnosis Methods 0.000 claims abstract description 62
- 230000002452 interceptive effect Effects 0.000 claims abstract description 55
- 230000009467 reduction Effects 0.000 claims description 58
- 239000003550 marker Substances 0.000 claims description 47
- 230000008859 change Effects 0.000 claims description 41
- 230000008569 process Effects 0.000 claims description 33
- 238000012360 testing method Methods 0.000 claims description 31
- 208000035475 disorder Diseases 0.000 claims description 18
- 230000006870 function Effects 0.000 claims description 15
- 239000000090 biomarker Substances 0.000 claims description 14
- 238000004891 communication Methods 0.000 claims description 11
- 238000004393 prognosis Methods 0.000 claims description 7
- 238000012790 confirmation Methods 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 230000004614 tumor growth Effects 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 description 33
- 238000004458 analytical method Methods 0.000 description 31
- 238000012795 verification Methods 0.000 description 27
- 201000011510 cancer Diseases 0.000 description 26
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 25
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 25
- 238000010586 diagram Methods 0.000 description 18
- 238000003860 storage Methods 0.000 description 17
- 238000012545 processing Methods 0.000 description 15
- 230000036541 health Effects 0.000 description 12
- 206010061289 metastatic neoplasm Diseases 0.000 description 10
- 238000004364 calculation method Methods 0.000 description 8
- 230000005750 disease progression Effects 0.000 description 8
- 102000015694 estrogen receptors Human genes 0.000 description 8
- 108010038795 estrogen receptors Proteins 0.000 description 8
- 208000037819 metastatic cancer Diseases 0.000 description 8
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 8
- 206010061818 Disease progression Diseases 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 102100033213 Teneurin-1 Human genes 0.000 description 6
- 238000009795 derivation Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000004590 computer program Methods 0.000 description 5
- 230000001394 metastastic effect Effects 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 4
- 230000004941 influx Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000013501 data transformation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011005 laboratory method Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000009397 lymphovascular invasion Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000000683 nonmetastatic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 102000003998 progesterone receptors Human genes 0.000 description 2
- 108090000468 progesterone receptors Proteins 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010055113 Breast cancer metastatic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102100035348 Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000008274 breast adenocarcinoma Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000012517 data analytics Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000013503 de-identification Methods 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- APTZNLHMIGJTEW-UHFFFAOYSA-N pyraflufen-ethyl Chemical compound C1=C(Cl)C(OCC(=O)OCC)=CC(C=2C(=C(OC(F)F)N(C)N=2)Cl)=C1F APTZNLHMIGJTEW-UHFFFAOYSA-N 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
- G06F3/048—Interaction techniques based on graphical user interfaces [GUI]
- G06F3/0484—Interaction techniques based on graphical user interfaces [GUI] for the control of specific functions or operations, e.g. selecting or manipulating an object, an image or a displayed text element, setting a parameter value or selecting a range
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Human Resources & Organizations (AREA)
- Strategic Management (AREA)
- Data Mining & Analysis (AREA)
- General Business, Economics & Management (AREA)
- Economics (AREA)
- Entrepreneurship & Innovation (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Tourism & Hospitality (AREA)
- Game Theory and Decision Science (AREA)
- Educational Administration (AREA)
- Development Economics (AREA)
- Databases & Information Systems (AREA)
- Marketing (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Human Computer Interaction (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/375,916 | 2021-07-14 | ||
| US17/375,916 US20210343420A1 (en) | 2020-01-09 | 2021-07-14 | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking |
| PCT/US2022/037017 WO2023287920A1 (fr) | 2021-07-14 | 2022-07-13 | Systèmes et procédés pour fournir des données de patient précises correspondant à des repères de progression pour fournir des options de traitement et un suivi de résultats |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240032920A true KR20240032920A (ko) | 2024-03-12 |
Family
ID=84920406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247004016A KR20240032920A (ko) | 2021-07-14 | 2022-07-13 | 치료 옵션 및 결과 추적을 제공하기 위한 진행 이정표에 대응하는 정확한 환자 데이터를 제공하기 위한 시스템 및 방법 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4371132A1 (fr) |
| JP (1) | JP2024529876A (fr) |
| KR (1) | KR20240032920A (fr) |
| CN (1) | CN117981012A (fr) |
| AU (1) | AU2022311798A1 (fr) |
| CA (1) | CA3225678A1 (fr) |
| IL (1) | IL310082A (fr) |
| WO (1) | WO2023287920A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011501276A (ja) * | 2007-10-12 | 2011-01-06 | ペイシェンツライクミー， インコーポレイテッド | 健康関連の転帰を予測するためのオンラインコミュニティを使用した自己改善方法 |
| US8694335B2 (en) * | 2011-02-18 | 2014-04-08 | Nuance Communications, Inc. | Methods and apparatus for applying user corrections to medical fact extraction |
| US10783448B2 (en) * | 2015-08-07 | 2020-09-22 | Flatiron Health, Inc. | Extracting facts from unstructured data |
| US10949395B2 (en) * | 2016-03-30 | 2021-03-16 | Salesforce.Com, Inc. | Cross objects de-duplication |
-
2022
- 2022-07-13 EP EP22842831.4A patent/EP4371132A1/fr active Pending
- 2022-07-13 WO PCT/US2022/037017 patent/WO2023287920A1/fr active Application Filing
- 2022-07-13 AU AU2022311798A patent/AU2022311798A1/en active Pending
- 2022-07-13 KR KR1020247004016A patent/KR20240032920A/ko unknown
- 2022-07-13 CA CA3225678A patent/CA3225678A1/fr active Pending
- 2022-07-13 IL IL310082A patent/IL310082A/en unknown
- 2022-07-13 JP JP2024501769A patent/JP2024529876A/ja active Pending
- 2022-07-13 CN CN202280060905.0A patent/CN117981012A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4371132A1 (fr) | 2024-05-22 |
| CA3225678A1 (fr) | 2023-01-19 |
| WO2023287920A1 (fr) | 2023-01-19 |
| JP2024529876A (ja) | 2024-08-14 |
| WO2023287920A9 (fr) | 2023-12-07 |
| CN117981012A (zh) | 2024-05-03 |
| AU2022311798A1 (en) | 2024-01-25 |
| IL310082A (en) | 2024-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12073342B2 (en) | Informatics platform for integrated clinical care | |
| Kim et al. | The evolving use of electronic health records (EHR) for research | |
| Fusar-Poli et al. | The science of prognosis in psychiatry: a review | |
| Kansagra et al. | Big data and the future of radiology informatics | |
| Newton et al. | Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network | |
| US20190156947A1 (en) | Automated information collection and evaluation of clinical data | |
| Ramakrishnan et al. | Mining electronic health records | |
| US20210343420A1 (en) | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking | |
| Kapoor et al. | Workflow applications of artificial intelligence in radiology and an overview of available tools | |
| US20140379379A1 (en) | System and method for real time clinical questions presentation and management | |
| US11984227B2 (en) | Automatically determining a medical recommendation for a patient based on multiple medical images from multiple different medical imaging modalities | |
| Chiudinelli et al. | Mining post-surgical care processes in breast cancer patients | |
| Bjarnadóttir et al. | Machine learning in healthcare: Fairness, issues, and challenges | |
| Bigus et al. | Information technology for healthcare transformation | |
| Vathy-Fogarassy et al. | Multi-level process mining methodology for exploring disease-specific care processes | |
| Valero-Ramon et al. | Analytical exploratory tool for healthcare professionals to monitor cancer patients’ progress | |
| Singhal et al. | Opportunities and challenges for biomarker discovery using electronic health record data | |
| KR102579786B1 (ko) | 임상 결과들을 개선하고 총 케어 비용을 감소시키기 위한 cna-유도 케어 | |
| US20210217527A1 (en) | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking | |
| KR20240032920A (ko) | 치료 옵션 및 결과 추적을 제공하기 위한 진행 이정표에 대응하는 정확한 환자 데이터를 제공하기 위한 시스템 및 방법 | |
| Delanerolle et al. | A perspective: use of machine learning models to predict the risk of multimorbidity | |
| Lu et al. | Modelling of cancer patient records: a structured approach to data mining and visual analytics | |
| Wei et al. | Prediction model of outpatient flow based on behaviour data of outpatients in a Chinese tertiary hospital | |
| Almario et al. | Informatics in medical product regulation: the right drug at the right dose for the right patient | |
| Navarro-Cerdán et al. | Effects of Comorbidities (Chronic Illness) on Hospitalization and Mortality Risks: Available to Clinicians Through an App |